| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.50M | 38.90M | 56.20M | 73.10M | 82.50M | 85.80M |
| Gross Profit | 11.80M | 14.80M | 19.60M | 20.90M | 27.60M | 22.50M |
| EBITDA | 15.10M | 16.40M | 7.50M | 6.90M | 15.80M | -10.50M |
| Net Income | 6.30M | 6.20M | 3.30M | -100.00K | 12.10M | -21.50M |
Balance Sheet | ||||||
| Total Assets | 26.30M | 28.70M | 22.40M | 30.60M | 36.80M | 35.60M |
| Cash, Cash Equivalents and Short-Term Investments | 3.00M | 4.30M | 5.00M | 7.10M | 9.20M | 6.90M |
| Total Debt | 8.80M | 8.80M | 19.90M | 20.00M | 20.20M | 20.40M |
| Total Liabilities | 36.40M | 38.10M | 52.50M | 32.40M | 35.30M | 78.60M |
| Stockholders Equity | -10.10M | -9.40M | -30.10M | -1.80M | 1.50M | -43.00M |
Cash Flow | ||||||
| Free Cash Flow | -2.60M | -1.50M | 2.50M | -800.00K | 2.70M | -4.40M |
| Operating Cash Flow | -2.60M | -1.50M | 4.80M | 1.50M | 5.60M | -4.00M |
| Investing Cash Flow | 15.50M | 14.80M | -2.30M | -2.30M | -2.90M | -400.00K |
| Financing Cash Flow | -12.60M | -14.00M | -4.50M | -1.20M | -500.00K | 5.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | £624.24M | 53.05 | 7.52% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £18.88M | -20.51 | -5.63% | ― | -1.65% | -454.55% | |
60 Neutral | £828.80M | -4.79 | -18.75% | ― | -20.36% | 44.33% | |
60 Neutral | £21.44M | 2.45 | 63.08% | ― | -1.96% | 28.69% | |
56 Neutral | £656.87M | 14.67 | ― | 1.40% | 3.94% | ― | |
45 Neutral | £13.74M | 2.14 | ― | ― | -30.78% | 86.44% |
Mothercare plc has disclosed significant share purchases by senior leadership, with chairman Clive Whiley increasing his beneficial interest from 8 million to 50 million shares through the acquisition of 42 million shares via the Zodiac Executive Pension Scheme, and chief financial officer Andy Cook acquiring 5 million shares. The transactions, executed on 23 December 2025 at 1.0p per share on the London Stock Exchange, materially raise insider ownership in the company, a move that may be interpreted by investors as a signal of management confidence in Mothercare’s prospects and alignment of executives’ interests with those of shareholders.
The most recent analyst rating on (GB:MTC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.
Mothercare reported a sharp contraction in its interim performance for the 26 weeks to 27 September 2025, with worldwide franchise retail sales down 25% to £90.7 million, turnover nearly halved to £11.6 million and adjusted EBITDA falling to £0.8 million, leading to an adjusted operating loss of £0.5 million. The decline reflects store closures in the Middle East and its planned exit from Boots, but the group has materially reduced net debt to £5.8 million and is positioning itself as a smaller, cash-generative business. Chairman Clive Whiley highlighted significant progress on strategic partnerships, including a South Asian joint venture with Reliance Brands and a 10‑year licensing deal with Turkish specialist Ebebek, both designed to rebuild scale, expand store footprints and open new routes to market. With Reliance targeting rapid expansion and Ebebek bringing substantial buying and distribution power, Mothercare aims to use these alliances, alongside planned refinancing of its facilities, to reignite growth in global retail sales and restore its market presence following years of geopolitical and pandemic-related disruption.
The most recent analyst rating on (GB:MTC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.
Mothercare held its Annual General Meeting on November 12, 2025, where all proposed resolutions were passed. The meeting saw a significant participation with proxy votes representing approximately 74% of the voting capital. Key resolutions included the approval of directors’ remuneration and policies, re-election of directors, appointment of RPGCC as the auditor, and authorization for share allotment and political donations. The successful passing of these resolutions indicates strong shareholder support and positions the company for continued strategic operations.
The most recent analyst rating on (GB:MTC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.
Mothercare plc has announced that its Pension Trustee has agreed to further defer pension contributions amounting to £3.0 million until March 2026, allowing the company to focus on growth opportunities and strategic discussions. Despite breaching a liquidity financial covenant, Mothercare continues to receive support from its lender, ensuring sufficient cash flow to maintain operations and explore options to mitigate the pension scheme deficit.
The most recent analyst rating on (GB:MTC) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.